Borah, P., Maitri, A., & Naithani, R. Bortezomib and low dose venetoclax therapy for relapsed/refractory B-cell acute lymphoblastic leukemia with IDH1 mutation. Elsevier.
Chicago Style (17th ed.) CitationBorah, Pronamee, Ayoniza Maitri, and Rahul Naithani. Bortezomib and Low Dose Venetoclax Therapy for Relapsed/refractory B-cell Acute Lymphoblastic Leukemia with IDH1 Mutation. Elsevier.
MLA (9th ed.) CitationBorah, Pronamee, et al. Bortezomib and Low Dose Venetoclax Therapy for Relapsed/refractory B-cell Acute Lymphoblastic Leukemia with IDH1 Mutation. Elsevier.
Warning: These citations may not always be 100% accurate.